skin rash
Aloe vera(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys “crystal”, in cataplasm1 note: "crystal" is the term used in Puerto Rico to refer to the transparent, gelatinous gel found in the internal part of the leaf. |
Recommandations
Preparation and posology References |
According to published and other information: Use for asthma, colds, baldness, cuts, bounds and skin rashes is classified as REC, based on the significant traditional use documented inthe TRAMIL surveys, toxicity studies, scientific validation, and published scientific information. Due to the health risks related to asthma, an initial medical evaluation is recommended. The use of this plant remedy should be considered complementary to medical treatment. There is no available information about its use for asthmatic crisis. For topical application, strict hygiene measures should be observed in order to avoid contamination or additional infection. Not for oral administration to pregnant or lactating women or to children under 5 years of age. The use of this resource should be avoided in cases of diabetes mellitus. The gel can cause reactions of hypersensitivity. It should not be used if it has turned a reddish color. |
When cutting out the gelatinous part of the leaf, avoid contact with the yellow juice. This juice can cause reactions of skin hypersensitivity or, if swallowed, it can have laxative effects. Use for asthma or colds: Peal the leaf and blend 15-30 grams (1-2 spoonfuls) of the “crystal” (gel, pulp, mesophyll) with 250 mL (1 cup) of water. Drink 1 cup 3 times a day. Prepare a decoction or infusion with 15-30 grams of gel in 250 mL (1 cup) of water. For decoction, boil for at least 10 minutes in covered pot. For infusion, add boiling water to 15-30 grams (1-2 spoonfuls) of gel, cover, and let cool. Drink 1 cup 3 times a day. For baldness, cuts, bounds and skin rashes: Wash and peal the leaf, cut 15-30 grams (1-2 spoonfuls) of gel and apply to affected area of skin or scalp, twice a day. |
1 BENEDETTI MD, 1994 2 FAUJOUR A, MURREY D, CHELTENHAM-CORBIN B, CARRINGTON S, 2003 3 DELAIGUE J, 2005 4 YAMAGUCHI I, MEGA N, SANADA H, 1993 5 GOWDA DC, NEELISIDDAIAH B, ANJANEYALU YV, 1979 6 MANDAL G, DAS A, 1980b 7 MANDAL G, GHOSH R, DAS A, 1984 8 HAQ N, HANNAN A, 1981 9 HART LA, VAN DER BERG AJJ, KUIS L, VAN DIJK H, LABADIE RP, 1989 10 McANALLEY BH, 1988 11 MANNA S, McANALLEY BH, 1993 12 YAMAGUCHI I, MEGA N, SANADA H, 1993 13 MARY NY, CHRISTENSEN BV, BEAL JL, 1956 14 HOLDSWORTH DK, 1971 15 PASZKIEWICZ-GADEK A, CHLABICZ J, GALASINSKI W, 1988 16 RAUWALD H, 1987 17 ZWAVING JH, ELEMA ET, 1976 18 WALLER GR, MANGIAFICO S, RITCHEY CR, 1978 19 WALLER GR, MANGIAFICO S, RITCHEY CR, CUMBERLAND CD, 1978 20 SUGA T, HIRATA T, 1983 21 MUKERJI B, 1953 22 MANDAL G, DAS A, 1980 23 MANDAL G, DAS A, 1980 24 GUARDARRAMA I, HERNANDEZ M, DIAZ-ACOSTA A, CARBALLO A, 1993 25GUARDARRAMA I, TORRES ORLANDO, HERNANDEZ M, RUIZ MM, GOMEZ M, CLAVO Y, 1994 26 RAINE TJ, LONDON MD, GOLUCH L, HEGGERS JP, ROBSON MC, 1980 27MARTINEZ MJ, BETANCOURT J, ALONSO N, 1996 28 GOTTSHALL RY, LUCAS E, LICKFELDT A, ROBERTS J, 1949 29 CACERES A, GIRON L, ALVARADO SR, TORRES MF, 1987 30 BUNYAPRAPHATSARA N, JIRAKULCAIWONG S, THIRAWARAPAN S, MANONUKUL J, 1996 31 ROWE TD, LOVELL BK, PARKS LM, 1941 32 DAVIS RH, LEITNER MG, RUSSO JM, BYRNE ME, 1989 33 DAVIS RH, DONATO J, HARTMAN G, HAAS R, 1994 34 DAVIS RH, AGNEW PS, SHAPIRO E, 1986 35 MOHSIN A, SHAH AH, AL-YAHYA MA, TARIQ M, TANIRA MO, AGEEL AM, 1989 36FURONES JA, MORON FJ, PINEDO Z, 1996 37 STRICKLAND FM, PELLEY RP, KRIPKE ML, 1994 38 ROMAN-RAMOS R, FLORES-SAENZ JL, PARTIDA-HERNANDEZ G, LARA-LEMUS A, ALARCON-AGUILAR F, 1991 39 DAVIS RH, LEITNER MG, RUSSO JM, 1987 40 DAVIS RH, LEITNER MG, RUSSO JM, 1988 41 DAVIS RH, KABBANI JM, MARO NP, 1986 42 DAVIS RH, LEITNER MG, RUSSO JM, MARO NP, 1987c 43 RODRIGUEZ-BIGAS M, CRUZ NI, SUÁREZ A, 1988 44 KIVETT WF, 1989 45 CARBAJAL D, CASACO A, ARRUZAZABALA L, GONZALEZ R, FUENTES V, 1991 46 DAVIS RH, DI DONATO JJ, JOHNSON RW, STEWART CB, 1994 47 LUSHBAUGH CC, HALE DB, 1953 48 ROVATTI B, BRENNAN RJ, 1959 49 NORTHWAY RB, 1975 50 COBBLE HH, 1975 51 FULTON JE, 1990 52 YAGI A, SHIDA T, NISHIMURA H, 1987 53 KAVOUSSI H, KAVOUSSI HP, 1993 54LEONJE, ROSALES V, ROSALES RA, PAVON V, 1999 55 VISUTHIKOSOL V, CHOWCHUEN B, SUKWANARAT Y, SRIURAIRATANA S, BOONPUCKNAVIG V, 1995 56 CREWE JE, 1939 57 SYED T, AHMAD S, HOLT A, AHMAD S, AHMAD S, AFZAL M, 1996 58 SYDISKIA RJ, OWEN DG, 1987 59RAMOS A, EDREIRA AYMEE, VILLESCUSA A, VIZOZO A, MARTINEZ MJ, 1996 60 VIZOSO A, RAMOS A, GARCIA A, PILOTO J, PAVON V, 2000 61 DHAR ML, DHAR MM, DHAWAN B, MEHROTRA B, RAY C, 1968 62 BHAKUNI D, DHAR ML, DHAR MM, DHAWAN BN, GUPTA B, SRIMALI RC, 1971 63 SHAH AH, QURESHI S, TARIQU M, AGEEL AM, 1989 64 YOKEL R, OGZEWALLA C, 1981 65 PRAKASH A, MATHUR R, 1976 66 SETHI N, NATH D, SING R, 1989 67 MORROW DM, RAPAPORT MJ, STRICK RA, 1980 68 PARRA AL, YHEBRA RS, SARDINAS IG, BUELA LI, 2001 69 Zambrano LE, 2007 70 BALZ E, BOYER A, BURAUD M, 2007 |
||
Momordica charantia(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaf and stem, bath and cataplasm7,13 |
Recommandations
Preparation and posology References |
According to published and other information: Use for furuncles and common cold is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies and available published scientific information. Use for dry skin conditions, itching, lice (pediculosis) and burns is classified as REC, based on the significant traditional use (OMS/WHO)4 documented in the TRAMIL surveys. For topical application, strict hygienic measures should be observed in order to avoid contamination or additional infection. Should there be a notable worsening of the patient’s condition, or should furuncles last more than 5 days, seek medical attention. Do not take orally during pregnancy due to risk of abortion. Not for use during lactation or by children under 3 years old. |
For skin conditions: Wash the aerial parts of the plant thoroughly and crush them. Apply 30 grams (a handful) of vegetal material on the affected area of skin 3 times a day. For common cold: There is no available information establishing a means of preparation and dosage other than that referred to by traditional use. |
1 CHARLES C, 1988 TRAMIL survey. Movement for Cultural Awareness MCA, Roseau, Dominica. 2 WENIGER B, ROUZIER M, 1986 Enquête TRAMIL. Service Oecuménique d'Entraide SOE, Port au Prince, Haïti. 3 LAGOS-WITTE S, 1988-1995 Encuestas TRAMIL. Laboratorio de Histología Vegetal y Etnobotánica, Departamento de Biología, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 4 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 5 WENIGER B, 1987-88 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 6 Castillo D, Rodriguez S, de los Santos C, Belen A, 2003 Encuesta TRAMIL (Zambrana, Cotuí). Dep. de Botánica, Jardín BotánicoNacional, Santo Domingo, República Dominicana. 7 Castillo D, Rodriguez S, de los Santos C, Belen A, 2003 Encuesta TRAMIL (region Este). Dep. de Botánica, Jardín BotánicoNacional, Santo Domingo, República Dominicana. 8 DELENS M, 1990 Encuesta TRAMIL en Barlovento, Edo. Miranda de Venezuela. Centro al Servicio de la Acción Popular CESAP, Caracas, Venezuela. 9 GIRON L, 1988 Encuesta TRAMIL (Costa atlántica). Centro Mesoamericano de Tecnología CEMAT, Guatemala. 10 O'REILLY A, 1992 TRAMIL survey. Chemistry & Food Technology Division, Ministry of Agriculture, Dunbars, Antigua & Barbuda. 11 OCAMPO R, 1988 Encuesta TRAMIL (Costa atlántica), Instituto de Desarrollo Agrario, Universidad de Costa Rica, San José, Costa Rica. 12 FAUJOUR A, MURREY D, CHELTENHAM-CORBIN B, CARRINGTON S, 2003 TRAMIL survey. IICA & UAG, Saint Thomas, Barbados. 13 BENEDETTI MD, 1994 Encuesta TRAMIL. Universidad de Puerto Rico, Mayagüez, Puerto Rico. 14 WHO, 1991 Pautas para la evaluación de medicamentos herbarios WHO/TRM/91.4 (original inglés). Programa de Medicina Tradicional, OMS, Ginebra, Suiza. 15 WENIGER B, SAVARY H, DAGUIHL R, 1984 Tri phytochimique de plantes de la liste TRAMIL. Laboratoire de chimie des substances naturelles, Faculté de médecine et de pharmacie, Université d'Etat d'Haïti, Port au Prince, Haïti. 16 HERRERA J, 1990 Determinación de actividades biológicas de vegetales utilizados en medicina tradicional. Informe TRAMIL. Dep. de Farmacología, Facultad de Salud, Universidad del Valle, Cali, Colombia. 17 DUKE JA, ATCHLEY AA, 1986 Handbook of proximate analysis tables of higher plants. Boca Raton, USA: CRC Press. p110. 18 YASUDA M, IWAMOTO M, OKABE H, YAMAUCHI T, 1984 Structures of momordicines I, II and III, the bitter principles in the leaves and vines of Momordica charantia. Chem Pharm Bull 32(5):2044-2047. 19 DHALLA NS, GUPTA KC, SASTRY MS, MALHOTRA CL, 1961 Chemical composition of the fruit of Momordica charantia. Indian J Pharmacy 23:128-130. 20 KANNA B, 1976 Insulin from Momordica charantia. Patent-Japan Kokai. 21 NG TB, YEUNG HW, 1984 Bioactive constituents of Cucurbitaceae plants with special emphasis on Momordica charantia and Trichosanthes kirilowii. Seoul, Korea: Proc. 5th. Symposium Medicinal Plants and Spices. 22 KHANNA P, MOHAN S, 1973 Isolation and identification of diosgenin and sterols from fruits and in vitro cultures ofMomordica charantia. Indian J Exp Biol11:58-60. 23 OKABE H, MIYAHARA K, YAMAGUCHI T, MIYAHARA K, KAWASAKI T, 1980 Studies on the constituents ofMomordica charantia L. I: Isolation and characterization of momordicosides A and B, glycosides of a pentahydroxy-cucurbitane triterpene. Chem Pharm Bull28(9):2753-2762. 24 RODRIGUEZ DB, RAYMUNDO LC, TUNG-CHING LEE, SIMPSON KL, CHICHESTER CO, 1976 Carotenoid pigment changes in ripening Momordica charantia fruits. Ann Bot (London)40:615-624. 25 LIN JY, HOU MJ, CHEN YC, 1978 Isolation of toxic and non-toxic lectins from the bitter pear melon (Momordica charantia). Toxicon16:653. 26 IYER RI, NAGAR PK, SIRCAR PK, 1981 Endogenous cytokinins in seeds of bittergourd Momordica charantia. Indian J Exp Biol19:766-767. 27 WONG CM, YEUNG HW, NG TB, 1985 Screening of Trichosanthes kirilowii,Momordica charantia andCucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity. J Ethnopharmacol 13(3):313-321. 28 YEUNG HW, LI WW, FENG Z, BARBIERI L, STIRPE F, 1988 Trichosanthin, alpha-momorcharin and beta-momorcharin: Identity of abortifacient and ribosome-inactivating protein. Int J Peptide Protein Res 31(3):265-268. 29 MIYAHARA Y, OKABE H, YAMAUCHI T, 1981 Studies on the constituents ofMomordica charantia L. II: Isolation and characterization of minor seed glycosides, momordicosides C, D and E. Chem Pharm Bull29(6):1561-1566. 30 SAUVAIN M, KODJOED JF, BERGRAVE SJ, BONNEVIE O, DEDET JP, 1986 Plantes fébrifuges en médecine traditionnelle en Haïti et en République Dominicaine et thérapie du paludisme. Rapport TRAMIL: ORSTOM, Cayenne, Guyane Française. 31 MORETTI C, 1989 Determinación de la actividad antimalárica de plantas utilizadas por la medicina tradicional (Momordica charantia). TRAMIL IV, Tela, Honduras, UNAH/enda-caribe. 32 CACERES A, JAUREGUI E, HERRERA D, LOGEMANN H, 1991 Plants used in Guatemala for the treatment of dermatomucosal infections. 1: Screening of 38 plant extracts for anticandidal activity. J Ethnopharmacol 33(3):277-283. 33 HEAL R, ROGERS E, WALLACE RT, STARNES O, 1950 A survey of plants for insecticidal activity. Lloydia13(2):89-162. 34 OGUNLANA EO, RAMSTAD E, 1975 Investigation into the antibacterial activities of local plants. Planta Med27(4):354-360. 35 HUSSAIN HSN, DEENI YY, 1991 Plants in Kano ethnomedicine; screening for antimicrobial activity and alkaloids. Int J Pharmacol29(1):51-56. 36 MANEELRT S, SATTHAMPONGSA A, 1978 Antimicrobial activity ofMomordica charantia. Undergraduate special project report. Bangkok, Thailand: Mahidol University. Faculty of Pharmacy. 37 LAL J, CHANDRA S, RAVIPRAKASH V, SABIR M, 1976 In vitro anthelmintic action of some indigenous medicinal plants on Ascardia galli worms. Indian J Physiol Pharmacol20(2):64-68. 38 BISWAS AR, RAMASWAMY S, BAPNA JS, 1991 Analgesic effect ofMomordica charantia seed extract in mice and rats. J Ethnopharmacol31(1):115-118. 39 MOKKHASMIT M, SAWASDIMONGKOL K, SATRAWAHA P, 1971 Study on toxicity of Thai medicinal plants. Bull Dept Med Sci 12(1/2):36-65. 40 GONZALEZ A, ALFONSO H, 1990 Evaluación de la toxicidad dérmica deMomordica charantia L.,Foeniculum vulgare Mill yCassia occidentalis L. en cobayos. Informe TRAMIL. Centro Nacional de Salud Animal, La Habana, Cuba. 41 GONZALEZ A, ALFONSO H, 1990 Evaluación de la toxicidad dérmica deMomordica charantia L. yCassia occidentalis L. en conejos. Informe TRAMIL. Centro Nacional de Salud Animal, La Habana, Cuba. 42 TABORA O, 1986 Estudio de toxicidad aguda en ratones de la fracción hipoglucemiante deMomordica charantia (Cucurbitaceae). Tegucigalpa, Honduras: IV Semana Científica Universidad Nacional Autónoma de Honduras UNAH. 43 SAKSENA SK, 1971 Study of antifertility activity of the leaves ofMomordica (karela). Indian J Physiol Pharmacol15(2):79-80. 44 PRAKASH AO, MATHUR R, 1976 Screening of Indian plants for antifertility activity. Indian J Exp Biol14(5):623-626. 45 SHARMA VN, SOGANI RK, ARORA RB, 1960 Some observations on hypoglycemic activity of Momordica charantia. Indian J Med Res48(4):471-477. 46 DIXIT VP, KHANNA P, BHARGAVA SK, 1978 Effects ofMomordica charantia fruit extract on the testicular function of dog. Planta Med34(3):280-286. 47 KOENTJORO-SOEHADI T, SANTA I, 1982 Perspectives of male contraception with regards to Indonesian traditional drugs. Bali, Indonesia: 2nd National Congress of Indonesian Society of Andrology. 48 KHAN AH, BURNEY A, 1962 A preliminary study of the hypoglycemic properties of indigenous plants. Pakistan J Med Res2:100-116. 49 WEST M, SIDRAK G, STREET S, 1971 The anti-growth properties of extracts from Momordica charantia. West Indian Med J20(1):25-34. 50 NG T, 1988 Effects of momorcharins on ovarian response to gonadotropin induced superovulation in mice. Int J Fertil33(2):123-128. 51 DELAIGUE J, 2005 TRAMIL survey. UAG & PRDI, Tobago House of Assembly, Scarborough, Tobago. |